1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol has been researched along with Allodynia in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dvorak, M; McGlone, F; Rukwied, R; Watkinson, A | 1 |
| Chapman, V; Clayton, NM; Elmes, SJR; Kendall, DA; Medhurst, SJ; Wilson, AW; Winyard, LA | 1 |
| Mitchell, VA; Vaughan, CW; Vuong, LA | 1 |
| Fox, A; Gentry, C; James, I; Kesingland, A; McNair, K; Patel, S; Urban, L | 1 |
| Chapman, V | 1 |
5 other study(ies) available for 1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol and Allodynia
| Article | Year |
|---|---|
Cannabinoid agonists attenuate capsaicin-induced responses in human skin.
Topics: Adult; Cannabinoid Receptor Modulators; Cannabinoids; Capsaicin; Dronabinol; Female; Humans; Hyperalgesia; Male; Pain Measurement; Skin | 2003 |
Activation of CB1 and CB2 receptors attenuates the induction and maintenance of inflammatory pain in the rat.
Topics: Analgesics; Animals; Cannabinoids; Carrageenan; Dronabinol; Drug Combinations; Hyperalgesia; Inflammation; Male; Rats; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Treatment Outcome; Weight-Bearing | 2005 |
Actions of N-arachidonyl-glycine in a rat neuropathic pain model.
Topics: Analgesics; Animals; Arachidonic Acids; Area Under Curve; Camphanes; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Glycine; Hyperalgesia; Male; Pain Measurement; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Sciatica | 2008 |
The role of central and peripheral Cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain.
Topics: Analgesics; Animals; Benzoxazines; Cannabinoids; Cyclohexanols; Disease Models, Animal; Dronabinol; Hyperalgesia; Morpholines; Naphthalenes; Pain Measurement; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Sciatica | 2001 |
Functional changes in the inhibitory effect of spinal cannabinoid (CB) receptor activation in nerve injured rats.
Topics: Animals; Cannabinoids; Dronabinol; Evoked Potentials; Hyperalgesia; Ligation; Male; Neural Inhibition; Pain Measurement; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Receptors, Drug; Spinal Cord; Spinal Nerves | 2001 |